Form 4: Doximity Director Sells Shares After Option Exercise

Doximity Director Kira Scherer Wampler exercised stock options and subsequently sold 2,000 Class A Common Stock shares for $66.44 each, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Kira Scherer Wampler, a Director at Doximity, Inc. (DOCS), executed transactions on November 3, 2025.
• Exercised 2,000 stock options to acquire 2,000 shares of Class B Common Stock at an exercise price of $1.54 per share.
• Immediately converted these 2,000 Class B Common Stock shares into 2,000 Class A Common Stock shares.
• Sold 2,000 Class A Common Stock shares at a price of $66.44 per share.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on November 12, 2024.
• Following these transactions, Wampler directly owns 19,839 shares of Class A Common Stock and 464,700 stock options for Class B Common Stock.

Sentiment

Score: 5

Explanation: Neutral. The filing reports routine insider transactions (option exercise and sale) conducted under a pre-arranged 10b5-1 plan, which is a standard practice and does not inherently indicate positive or negative sentiment about the company's future prospects.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent approach to insider stock sales.
• The exercise of options and subsequent sale demonstrates liquidity for the director and a realization of value from previously granted equity.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the director's direct equity stake in the company.

Industry Context

Insider transactions like this are common across all industries, particularly for directors and executives who receive equity compensation. The use of a Rule 10b5-1 plan is a standard practice to manage such transactions in compliance with insider trading regulations.

Stakeholder Impact

• Shareholders: The sale by a director slightly reduces insider ownership, which could be viewed neutrally or slightly negatively, though it's a common occurrence for equity compensation. The pre-planned nature mitigates concerns.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan. Such transactions are common for executives and directors managing their equity compensation and do not typically signal a change in the company's fundamental outlook or performance. While an insider sale reduces direct ownership, the pre-planned nature suggests it's not based on new, material non-public information. Therefore, this filing alone does not provide sufficient new information to warrant a change in investment recommendation; a 'hold' stance remains appropriate, pending further fundamental analysis of Doximity's business operations and financial results.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Kira Scherer Wampler, Rule 10b5-1, Director Transaction